Older adults losing muscle strength now have a clearer molecular explanation for why regular physical activity slows that ...
Laboratory experiments have identified a gene that appears to interfere with protein maintenance in aging muscle. The ...
A new study identified DEAF1 as a gene involved in muscle ageing and repair. Exercise appeared to lower DEAF1 activity, helping older muscles clear damage and restore healthier protein balance. The ...
A phase 1, first-in-human, dose-escalation and biomarker trial of liposomal gemcitabine (FF-10832) in patients with advanced solid tumors. This is an ASCO Meeting Abstract from the 2022 ASCO Annual ...
To coordinate their size and growth with current environmental conditions, cells rely on the mechanistic target of rapamycin complex 1 (mTORC1) pathway, which senses cellular stresses, growth factors, ...
REVTORPYK is the first and only FDA-approved therapy that inhibits all class I PI3K isoforms (α, β, δ, γ) and mTOR complexes mTORC1 and mTORC2 In the Phase 3 VIKTORIA-1 trial, REVTORPYK combined with ...